Efficacy and safety of praziquantel combined with artemisinin derivatives versus praziquantel monotherapy for schistosomiasis: a meta-analysis of randomized controlled trials
{{output}}
Background: Praziquantel (PZQ) is the mainstay treatment for schistosomiasis, but its efficacy against juvenile schistosomes is limited, which can lead to treatment failure and reinfection. Artemisinin derivatives (ARTs) exhibit ... ...
